Acerus Pharmaceuticals Corporation issued the following announcement on April 5.
Acerus Pharmaceuticals Corporation (TSX:ASP) today announced that is has been selected to present at the annual CHINABIO® Partnering Forum2018 to be held in Suzhou, China, on April 25 and 26, 2018.
This life science industry event is expected to attract over 1000 attendees from around the world focused on partnering opportunities and cross-border relationships in China. Acerus will present on it intranasal gel products NATESTO® and TEFINA™, as well as its Corporate Partnering Strategy Forum on April 26 at 15:15 CST (ChinaStandard Time).
Acerus has already partnered NATESTO®, a testosterone nasal gel for testosterone replacement therapy in 30 countries outside Canada and continues to actively seek partners to expand its global reach. The Company is also actively seeking co-development partner for TEFINA™, a clinical stage product aimed at addressing a significant unmet need for women with female sexual dysfunction.
Acerus will also be available for one-to-one partnering meetings. Interested parties may schedule meetings with Acerus through the conference website for the CHINABIO® partnering forum. (https://ebdgroup.knect365.com/chinabio-partnering/)
Original source: http://www.aceruspharma.com/English/news/press-release-details/2018/Acerus-to-Present-at-the-Next-CHINABIO-Partnering-Forum/default.aspx